Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Diagnostic Test for Hepatitis C Developed with Scrapbooking Tool

By LabMedica International staff writers
Posted on 17 Jun 2014
Scientists have used a novel approach to develop a paper-based multiplex diagnostic immunoassay that could help curb the hepatitis C pandemic.

For patients already diagnosed with Hepatitis C virus (HCV), the US Food and Drug Administration (FDA) approved two new treatments in late 2013, and others are on the way. More...
Scientists Xuan Mu, Zhi Zheng, and colleagues, of the Chinese Academy of Medical Sciences (Beijing, China), are solving another critical problem—identifying the millions more who unknowingly have the virus and pass it on. They point out that although HCV infects an estimated 150 million people worldwide, current diagnostic testing involves initial screening then a costly second test for confirmation. The extra office visits, money, and time required for definitive diagnosis means that many people are missed as they cannot or do not follow through.

To make diagnosis much more accessible, the researchers applied the recent development of inexpensive paper-based medical technologies to immunoassay detection of human IgG anti-HCV. In a new report they present a novel approach: taking example from the popular scrapbooking pastime, they used a flower-shaped metal paper-puncher on nitrocellulose paper subtrate. This solved the problem of patterning the highly flammable nitrocellulose—without using heat. The flower shape itself provides multiple testing zones, enabling development of a multiplex test. The immunoassays can be conducted such that both HCV tests can be conducted simultaneously on one patient sample on a single flower-shaped paper – at lower cost and in minutes instead of hours.

The work highlights the potential of microfluidic paper-based immunoassays in tackling the diagnostic challenge for the HCV pandemic as well as other diseases. Xuan M., et al. described the new test in the American Chemical Society journal Analytical Chemistry, May 5, 2014, online, ahead of print.

Related Links:

Chinese Academy of Medical Sciences



New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Portable Electronic Pipette
Mini 96
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.